|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q3 FY2013
As of Sep 30, 2013
|
Q2 FY2013
As of Jun 30, 2013
|
Q1 FY2013
As of Mar 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q3 FY2012
As of Sep 30, 2012
|
Q2 FY2012
As of Jun 30, 2012
|
Q1 FY2012
As of Mar 31, 2012
|
Q4 FY2011
As of Dec 31, 2011
|
Q3 FY2011
As of Sep 30, 2011
|
Q2 FY2011
As of Jun 30, 2011
|
Q1 FY2011
As of Mar 31, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Current assets: | |||||||||||||||
| Cash and cash equivalents | |||||||||||||||
| Short-term available-for-sale investments | |||||||||||||||
| Accounts receivable, net | |||||||||||||||
| Inventories | |||||||||||||||
| Prepaid expenses and other current assets | |||||||||||||||
| Total current assets | |||||||||||||||
| Restricted cash | |||||||||||||||
| Long-term available-for-sale investments | |||||||||||||||
| Property and equipment, net | |||||||||||||||
| Intangible assets, net | |||||||||||||||
| Goodwill | |||||||||||||||
| Other non-current assets | |||||||||||||||
| Total assets | |||||||||||||||
| Liabilities and Stockholders’ Equity | |||||||||||||||
| Current liabilities: | |||||||||||||||
| Accounts payable | |||||||||||||||
| Accrued compensation | |||||||||||||||
| Accrued expenses and other current liabilities | |||||||||||||||
| Deferred revenues | |||||||||||||||
| Current maturities of convertible senior notes | |||||||||||||||
| Contingent consideration | |||||||||||||||
| Current maturities of long-term debt | |||||||||||||||
| Total current liabilities | |||||||||||||||
| Convertible senior notes | |||||||||||||||
| Other long-term debt | |||||||||||||||
| Deferred revenues | |||||||||||||||
| Contingent consideration, non-current portion | |||||||||||||||
| Other non-current liabilities | |||||||||||||||
| Total liabilities | |||||||||||||||
| Stockholders’ equity: | |||||||||||||||
| Preferred stock, par value of $0.001; 10,000 shares authorized; no shares issued and outstanding at September 30, 2014 and December 31, 2013 | |||||||||||||||
| Common stock, par value of $0.001; 250,000 shares authorized at September 30, 2014 and December 31, 2013; 51,603 and 51,530 shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively | |||||||||||||||
| Additional paid-in capital | |||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||
| Accumulated deficit | |||||||||||||||
| Total stockholders’ equity | |||||||||||||||
| Total liabilities and stockholders’ equity |
Loading...
